Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07506551 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 7, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description expanded, about 3 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Determination of proteins and their levels in the vitreous of eyes with or without pseudoexfoliation syndrome (PEX)
Trial Details
NCT Number NCT07506551
Lead Sponsor Prim. Prof. Dr. Oliver Findl, MBA
Conditions
(from sponsor)		 Pseudoexfoliation Syndrome
Related terms Exfoliation Syndrome
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov